Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura M Bohn

Showing results (1-10 of 105) with videos related to

Pageof 11
Sort By:
Molecular Pharmacology|January 26, 2007
Constitutive trafficking--more than just running in circles?Laura M Bohn
Current Opinion in Cell Biology|April 1, 2014
Functional selectivity of GPCR signaling in animalsLei Zhou, Laura M Bohn
ACS Medicinal Chemistry Letters|July 26, 2017
Seeking (and Finding) Biased Ligands of the Kappa Opioid ReceptorLaura M Bohn, Jeffrey Aubé
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 8, 2010
Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivoCullen L Schmid, Laura M Bohn
Drug Discovery Today. Technologies|January 11, 2011
Seeking Ligand Bias: Assessing GPCR Coupling to Beta-Arrestins for Drug DiscoveryLaura M Bohn, Patricia H McDonald
Pharmacology & Therapeutics|December 23, 2008
Physiological and pharmacological implications of beta-arrestin regulationCullen L Schmid, Laura M Bohn
Current Opinion in Pharmacology|August 29, 2006
Opioid receptor signaling: relevance for gastrointestinal therapyLaura M Bohn, Kirsten M Raehal
Critical Reviews in Biochemistry and Molecular Biology|October 8, 2010
Serotonin receptor signaling and regulation via β-arrestinsLaura M Bohn, Cullen L Schmid
Neuropharmacology|August 18, 2010
The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeuticsKirsten M Raehal, Laura M Bohn
Handbook of Experimental Pharmacology|December 3, 2013
β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesiaKirsten M Raehal, Laura M Bohn
Pageof 11

Showing results (1-10 of 105) with videos related to

Sort By:
Pageof 11
Molecular Pharmacology|January 26, 2007
Constitutive trafficking--more than just running in circles?Laura M Bohn
Current Opinion in Cell Biology|April 1, 2014
Functional selectivity of GPCR signaling in animalsLei Zhou, Laura M Bohn
ACS Medicinal Chemistry Letters|July 26, 2017
Seeking (and Finding) Biased Ligands of the Kappa Opioid ReceptorLaura M Bohn, Jeffrey Aubé
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 8, 2010
Serotonin, but not N-methyltryptamines, activates the serotonin 2A receptor via a ß-arrestin2/Src/Akt signaling complex in vivoCullen L Schmid, Laura M Bohn
Drug Discovery Today. Technologies|January 11, 2011
Seeking Ligand Bias: Assessing GPCR Coupling to Beta-Arrestins for Drug DiscoveryLaura M Bohn, Patricia H McDonald
Pharmacology & Therapeutics|December 23, 2008
Physiological and pharmacological implications of beta-arrestin regulationCullen L Schmid, Laura M Bohn
Current Opinion in Pharmacology|August 29, 2006
Opioid receptor signaling: relevance for gastrointestinal therapyLaura M Bohn, Kirsten M Raehal
Critical Reviews in Biochemistry and Molecular Biology|October 8, 2010
Serotonin receptor signaling and regulation via β-arrestinsLaura M Bohn, Cullen L Schmid
Neuropharmacology|August 18, 2010
The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeuticsKirsten M Raehal, Laura M Bohn
Handbook of Experimental Pharmacology|December 3, 2013
β-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesiaKirsten M Raehal, Laura M Bohn
Pageof 11